IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,383,000 | +19.5% | 302,571 | 0.0% | 0.62% | +18.2% |
| Q2 2022 | $11,201,000 | -0.1% | 302,571 | 0.0% | 0.53% | +8.2% |
| Q1 2022 | $11,207,000 | +21.8% | 302,571 | +0.0% | 0.49% | +9.9% |
| Q4 2021 | $9,203,000 | -9.3% | 302,421 | -0.0% | 0.44% | -21.2% |
| Q3 2021 | $10,147,000 | -16.1% | 302,521 | -0.2% | 0.56% | -19.1% |
| Q2 2021 | $12,093,000 | -11.3% | 303,150 | -0.0% | 0.70% | -25.3% |
| Q1 2021 | $13,633,000 | -49.3% | 303,220 | -36.2% | 0.93% | -51.4% |
| Q4 2020 | $26,883,000 | -1.5% | 475,461 | -17.4% | 1.92% | -12.6% |
| Q3 2020 | $27,306,000 | -31.4% | 575,478 | -14.8% | 2.19% | -34.4% |
| Q2 2020 | $39,826,000 | +24.7% | 675,478 | 0.0% | 3.34% | +8.6% |
| Q1 2020 | $31,937,000 | -21.7% | 675,478 | 0.0% | 3.08% | -1.8% |
| Q4 2019 | $40,806,000 | +0.8% | 675,478 | 0.0% | 3.13% | -6.4% |
| Q3 2019 | $40,468,000 | -6.8% | 675,478 | 0.0% | 3.35% | -7.0% |
| Q2 2019 | $43,413,000 | -20.8% | 675,478 | 0.0% | 3.60% | -31.7% |
| Q1 2019 | $54,829,000 | +39.3% | 675,478 | 0.0% | 5.27% | +29.1% |
| Q4 2018 | $39,374,000 | +13.0% | 675,478 | 0.0% | 4.08% | +34.1% |
| Q3 2018 | $34,841,000 | +23.8% | 675,478 | +0.0% | 3.04% | +16.3% |
| Q2 2018 | $28,146,000 | -5.5% | 675,461 | -0.1% | 2.62% | -6.3% |
| Q1 2018 | $29,796,000 | -12.4% | 675,961 | +0.0% | 2.79% | -9.2% |
| Q4 2017 | $33,997,000 | -0.8% | 675,891 | 0.0% | 3.07% | -11.6% |
| Q3 2017 | $34,268,000 | -0.3% | 675,891 | 0.0% | 3.48% | -4.0% |
| Q2 2017 | $34,383,000 | +26.6% | 675,891 | +0.0% | 3.62% | +25.2% |
| Q1 2017 | $27,169,000 | -16.0% | 675,843 | 0.0% | 2.89% | -19.9% |
| Q4 2016 | $32,326,000 | +30.4% | 675,843 | -0.1% | 3.62% | +24.7% |
| Q3 2016 | $24,786,000 | +57.4% | 676,472 | +0.0% | 2.90% | +53.3% |
| Q2 2016 | $15,751,000 | -42.5% | 676,298 | -0.0% | 1.89% | -44.1% |
| Q1 2016 | $27,392,000 | -34.6% | 676,339 | -0.0% | 3.38% | -35.8% |
| Q4 2015 | $41,888,000 | – | 676,379 | – | 5.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |